Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monica Messina

Showing results (11-20 of 59) with videos related to

Pageof 6
Sort By:
The Journal of Experimental Medicine|October 16, 2013
Genetic lesions associated with chronic lymphocytic leukemia transformation to Richter syndromeGiulia Fabbri, Hossein Khiabanian, Antony B Holmes, et al.
Leukemia Research|December 29, 2009
Gene expression profile of protein kinases reveals a distinctive signature in chronic lymphocytic leukemia and in vitro experiments support a role of second generation protein kinase inhibitorsSimona Tavolaro, Sabina Chiaretti, Monica Messina, et al.
Genes & Cancer|September 9, 2011
Critical Role of c-Myc in Acute Myeloid Leukemia Involving Direct Regulation of miR-26a and Histone Methyltransferase EZH2Beatrice Salvatori, Ilaria Iosue, Nkerorema Djodji Damas, et al.
British Journal of Haematology|June 1, 2011
AICDA expression in BCR/ABL1-positive acute lymphoblastic leukaemia is associated with a peculiar gene expression profileMonica Messina, Sabina Chiaretti, Ilaria Iacobucci, et al.
Hematological Oncology|August 17, 2021
Applicability of droplet digital polymerase chain reaction for minimal residual disease monitoring in Philadelphia-positive acute lymphoblastic leukaemiaMichela Ansuinelli, Irene Della Starza, Alessia Lauretti, et al.
Frontiers in Oncology|August 27, 2019
Minimal Residual Disease in Acute Lymphoblastic Leukemia: Technical and Clinical AdvancesIrene Della Starza, Sabina Chiaretti, Maria S De Propris, et al.
British Journal of Haematology|October 20, 2018
Unravelling the suboptimal response of TP53-mutated chronic lymphocytic leukaemia to ibrutinibAnna Guarini, Nadia Peragine, Monica Messina, et al.
Leukemia & Lymphoma|March 7, 2014
NOTCH1, SF3B1, BIRC3 and TP53 mutations in patients with chronic lymphocytic leukemia undergoing first-line treatment: correlation with biological parameters and response to treatmentSabina Chiaretti, Marilisa Marinelli, Ilaria Del Giudice, et al.
Ejhaem|December 18, 2024
A GIMEMA survey on therapeutic use and response rates of FLT3 inhibitors in acute myeloid leukemia: Insights from Italian real-world practiceMonica Messina, Alfonso Piciocchi, Leonardo M Siena, et al.
Journal of Clinical Medicine|August 26, 2023
Italian Physicians' Perceptions about the Role of Asciminib in Later Lines Chronic Myeloid Leukemia in Clinical Practice: A GIMEMA SurveyMassimo Breccia, Alfonso Piciocchi, Elisabetta Abruzzese, et al.
Pageof 6

Showing results (11-20 of 59) with videos related to

Sort By:
Pageof 6
The Journal of Experimental Medicine|October 16, 2013
Genetic lesions associated with chronic lymphocytic leukemia transformation to Richter syndromeGiulia Fabbri, Hossein Khiabanian, Antony B Holmes, et al.
Leukemia Research|December 29, 2009
Gene expression profile of protein kinases reveals a distinctive signature in chronic lymphocytic leukemia and in vitro experiments support a role of second generation protein kinase inhibitorsSimona Tavolaro, Sabina Chiaretti, Monica Messina, et al.
Genes & Cancer|September 9, 2011
Critical Role of c-Myc in Acute Myeloid Leukemia Involving Direct Regulation of miR-26a and Histone Methyltransferase EZH2Beatrice Salvatori, Ilaria Iosue, Nkerorema Djodji Damas, et al.
British Journal of Haematology|June 1, 2011
AICDA expression in BCR/ABL1-positive acute lymphoblastic leukaemia is associated with a peculiar gene expression profileMonica Messina, Sabina Chiaretti, Ilaria Iacobucci, et al.
Hematological Oncology|August 17, 2021
Applicability of droplet digital polymerase chain reaction for minimal residual disease monitoring in Philadelphia-positive acute lymphoblastic leukaemiaMichela Ansuinelli, Irene Della Starza, Alessia Lauretti, et al.
Frontiers in Oncology|August 27, 2019
Minimal Residual Disease in Acute Lymphoblastic Leukemia: Technical and Clinical AdvancesIrene Della Starza, Sabina Chiaretti, Maria S De Propris, et al.
British Journal of Haematology|October 20, 2018
Unravelling the suboptimal response of TP53-mutated chronic lymphocytic leukaemia to ibrutinibAnna Guarini, Nadia Peragine, Monica Messina, et al.
Leukemia & Lymphoma|March 7, 2014
NOTCH1, SF3B1, BIRC3 and TP53 mutations in patients with chronic lymphocytic leukemia undergoing first-line treatment: correlation with biological parameters and response to treatmentSabina Chiaretti, Marilisa Marinelli, Ilaria Del Giudice, et al.
Ejhaem|December 18, 2024
A GIMEMA survey on therapeutic use and response rates of FLT3 inhibitors in acute myeloid leukemia: Insights from Italian real-world practiceMonica Messina, Alfonso Piciocchi, Leonardo M Siena, et al.
Journal of Clinical Medicine|August 26, 2023
Italian Physicians' Perceptions about the Role of Asciminib in Later Lines Chronic Myeloid Leukemia in Clinical Practice: A GIMEMA SurveyMassimo Breccia, Alfonso Piciocchi, Elisabetta Abruzzese, et al.
Pageof 6